Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.59% |
| 2 | Technology | 20.43% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Healthcare | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Lowe's Companies
LOW
$110B
| $2.5B | 0.18% |
10,739,240
+364,065
| +4% | +$89.6M |
2013 Q2
47 quarters
|
|
102
Sherwin-Williams
SHW
$80.7B
| $2.48B | 0.18% |
7,097,315
+165,828
| +2% | +$58.2M |
2013 Q2
47 quarters
|
|
103
Arthur J. Gallagher & Co
AJG
$64.6B
| $2.47B | 0.18% |
7,141,464
+658,613
| +10% | +$208M |
2013 Q2
47 quarters
|
|
104
Vanguard Dividend Appreciation ETF
VIG
$113B
| $2.43B | 0.17% |
12,530,003
+106,549
| +0.9% | +$21.2M |
2013 Q2
47 quarters
|
|
105
Cloudflare
NET
$104B
| $2.43B | 0.17% |
21,552,659
-1,629,838
| -7% | -$216M |
2019 Q3
22 quarters
|
|
106
Union Pacific
UNP
$171B
| $2.43B | 0.17% |
10,278,220
+561,607
| +6% | +$135M |
2013 Q2
47 quarters
|
|
107
GE Aerospace
GE
$327B
| $2.42B | 0.17% |
12,081,032
+241,476
| +2% | +$47.5M |
2013 Q2
47 quarters
|
|
108
Prologis
PLD
$119B
| $2.37B | 0.17% |
21,167,320
+2,497,937
| +13% | +$289M |
2013 Q2
47 quarters
|
|
109
Caterpillar
CAT
$337B
| $2.36B | 0.17% |
7,168,773
-348,691
| -5% | -$124M |
2013 Q2
47 quarters
|
|
110
Fiserv Inc
FISV
$25.1B
| $2.32B | 0.17% |
10,517,355
+217,660
| +2% | +$47.7M |
2013 Q2
47 quarters
|
|
111
Stryker
SYK
$113B
| $2.28B | 0.16% |
6,122,619
+559,172
| +10% | +$213M |
2013 Q2
47 quarters
|
|
112
Lockheed Martin
LMT
$127B
| $2.23B | 0.16% |
4,983,434
-234,309
| -4% | -$108M |
2013 Q2
47 quarters
|
|
113
Gilead Sciences
GILD
$193B
| $2.22B | 0.16% |
19,800,980
-269,483
| -1% | -$27.8M |
2013 Q2
47 quarters
|
|
114
Strategy Inc
MSTR
$57.5B
| $2.22B | 0.16% |
7,683,940
+2,425,799
| +46% | +$770M |
2013 Q2
47 quarters
|
|
115
iShares MSCI EAFE ETF
EFA
$76.8B
| $2.18B | 0.16% |
26,728,419
+3,179,456
| +14% | +$256M |
2013 Q2
47 quarters
|
|
116
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $2.15B | 0.15% |
36,920,356
+926,769
| +3% | +$57.6M |
2013 Q2
47 quarters
|
|
117
iShares Russell Mid-Cap Growth ETF
IWP
$18.8B
| $2.15B | 0.15% |
18,305,885
+231,492
| +1% | +$29.8M |
2013 Q2
47 quarters
|
|
118
Texas Instruments
TXN
$255B
| $2.14B | 0.15% |
11,916,908
-534,401
| -4% | -$100M |
2013 Q2
47 quarters
|
|
119
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $2.13B | 0.15% |
47,169,514
-264,823
| -0.6% | -$11.9M |
2013 Q2
47 quarters
|
|
120
Zoetis
ZTS
$32.5B
| $2.1B | 0.15% |
12,746,043
+901,376
| +8% | +$150M |
2013 Q2
47 quarters
|
|
121
Northrop Grumman
NOC
$73.1B
| $2.09B | 0.15% |
4,082,612
-75,818
| -2% | -$36.2M |
2013 Q2
47 quarters
|
|
122
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $2.08B | 0.15% |
32,126,028
+1,430,716
| +5% | +$96M |
2013 Q2
47 quarters
|
|
123
Roper Technologies
ROP
$37.6B
| $2.08B | 0.15% |
3,521,305
+73,606
| +2% | +$41.3M |
2013 Q2
47 quarters
|
|
124
Citigroup
C
$208B
| $2.06B | 0.15% |
29,013,098
+469,191
| +2% | +$35.8M |
2013 Q2
47 quarters
|
|
125
Pfizer
PFE
$168B
| $2.04B | 0.15% |
80,442,317
+6,544,527
| +9% | +$171M |
2013 Q2
47 quarters
|
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 407 new, 3,433 increased, 3,304 reduced and 268 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 407 new positions and closed 268 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.